BioPharma Deals – The Survival Series
ID: 2188888
(firmenpresse) - Considering the tightening capital markets, evolving regulatory landscapes, and increasingly strategic dealmaking, a new industry event is stepping in to guide biopharma professionals through the storm. BioPharma Deals: The Survival Series, a Strategic conference designed for business development, licensing, and investment leaders, will take place on 24-25 November, 2025 in Munich, Germany.
This focused event aims to provide real-world strategies, tactical insights, and actionable solutions to the most pressing dealmaking and funding challenges faced by biotech and pharma companies today. Attendees will gain insider perspectives from seasoned executives, investors, and legal experts navigating the current environment and forging new paths forward.
Highlights Include:
Opening Industry Keynotes & CEO Insights
Gain strategic perspectives from senior biopharma executives and investment leaders navigating today’s dynamic dealmaking landscape.
Case Studies & Expert Panel Sessions
Explore real-life transactions and hear candid insights on licensing, M&A, and collaborative deal models across various stages and regions.
Hands-On Workshops & Practical Frameworks
Sharpen your approach to deal structuring, term sheet design, valuation methodology, and investor engagement—tailored to the current market reality.
Networking Roundtables & 1:1 Partnering
Engage directly with key stakeholders from biotech, pharma, and investment communities through curated networking formats and private meetings.
Whether you're seeking capital, sourcing innovation, or recalibrating your growth strategy, BioPharma Deals: The Survival Series offers a rare opportunity to reset and realign in an uncertain market.
For media inquiries, speaking opportunities, or partnership requests, please contact:Kelly Rose
kelly@biopharmadeals.com
Unternehmensinformation / Kurzprofil:
BioPharma Deals: The Survival Series brings together leaders from biotech, pharma, investment, CRO/CDMO, legal, and advisory sectors for a high-impact event focused on pragmatic deal-making, new financing models, early IPOs, and unconventional partnerships.
Kelly Rose
kelly(at)biopharmadeals.com
Datum: 04.08.2025 - 07:05 Uhr
Sprache: Deutsch
News-ID 2188888
Anzahl Zeichen: 1992
Kontakt-Informationen:
Ansprechpartner: Kelly Rose
Stadt:
Munich
Telefon: +447448553670
Kategorie:
Pharma
Meldungsart: Messeinformation
Versandart: Veröffentlichung
Freigabedatum: 08.04.2025
Diese Pressemitteilung wurde bisher 180 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioPharma Deals – The Survival Series"
steht unter der journalistisch-redaktionellen Verantwortung von
BioPharma Deals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
